References
- Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362(6423):801–809. doi:https://doi.org/10.1038/362801a0.
- Chen KC, Juo SH. MicroRNAs in atherosclerosis. Kaohsiung J Med Sci. 2012;28(12):631–640. doi:https://doi.org/10.1016/j.kjms.2012.04.001.
- Zhang L, Cheng HL, Yue YX, Li SZ, Zhang DP, He RL . H19 knockdown suppresses proliferation and induces apoptosis by regulating miR-148b/WNT/β-catenin in ox-LDL -stimulated vascular smooth muscle cells . J Biomed Sci. 2018;25(1):11. doi:https://doi.org/10.1186/s12929-018-0418-4.
- Zhang L, Cheng HL, Yue YX, Li SZ, Zhang DP, He RL. TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1. Cardiovasc Pathol. 2018;33:6–15. doi:https://doi.org/10.1016/j.carpath.2017.11.004.
- Bennett MR, Sinha S, Owens GK. Vascular smooth muscle cells in atherosclerosis. Circ Res. 2016;118(4):692–702. doi:https://doi.org/10.1161/CIRCRESAHA.115.306361.
- Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004;20:781–810. doi:https://doi.org/10.1146/annurev.cellbio.20.010403.113126.
- Clevers H. Wnt/beta-catenin signaling in development and disease. Cell. 2006;127(3):469–480. doi:https://doi.org/10.1016/j.cell.2006.10.018.
- Gavin BJ, McMahon JA, McMahon AP. Expression of multiple novel Wnt-1/int-1-related genes during fetal and adult mouse development. Genes Dev. 1990;4(12B):2319–2332. doi:https://doi.org/10.1101/gad.4.12b.2319.
- Nusse R, Varmus HE. Wnt genes. Cell. 1992; 69(7):1073–1087. doi:https://doi.org/10.1016/0092-8674(92)90630-u.
- Bhatt PM, Lewis LC, House DL, et al. Increased Wnt5a mRNA expression in advanced atherosclerotic lesions, and oxidized LDL treated human monocyte-derived macrophages. Open Circ Vasc J. 2012;5:1–7. doi:https://doi.org/10.2174/1877382601205010001.
- Cheng CW, Yeh JC, Fan TP, Smith SK, Charnock-Jones DS. Wnt5a-mediated non-canonical Wnt signalling regulates human endothelial cell proliferation and migration. Biochem Biophys Res Commun. 2008;365(2):285–290. doi:https://doi.org/10.1016/j.bbrc.2007.10.166.
- Liu D, Wang XY, Zhang MJ, et al. WISP1 alleviates lipid deposition in macrophages via the PPARγ/CD36 pathway in the plaque formation of atherosclerosis. J Cell Mol Med. 2020;24(20):11729–11741. doi:https://doi.org/10.1111/jcmm.15783.
- Eulalio A, Huntzinger E, Izaurralde E. Getting to the root of miRNA-mediated gene silencing. Cell. 2008;132(1):9–14. doi:https://doi.org/10.1016/j.cell.2007.12.024.
- Quintavalle M, Condorelli G, Elia L. Arterial remodeling and atherosclerosis: miRNAs involvement. Vascul Pharmacol. 2011;55(4):106–110. doi:https://doi.org/10.1016/j.vph.2011.08.216.
- Sun X, Belkin N, Feinberg MW. Endothelial microRNAs and atherosclerosis. Curr Atheroscler Rep. 2013;15(12):372 doi:https://doi.org/10.1007/s11883-013-0372-2.
- Zhu JM, Liu B, Wang ZY, et al. Exosomes from nicotine-stimulated macrophages accelerate atherosclerosis through miR-21-3p/PTEN-mediated VSMC migration and proliferation. Theranostics. 2019;9(23):6901–6919. doi:https://doi.org/10.7150/thno.37357.
- Liu HT, Chen HW, Deng X, et al. Knockdown of TRIM28 inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration. Chem Biol Interact. 2019;311:108772. doi:https://doi.org/10.1016/j.cbi.2019.108772.
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408. doi:https://doi.org/10.1006/meth.2001.1262.
- Chen JX, Chen JD, Gong YH, et al. C14orf166 is a biomarker for predicting hepatocellular carcinoma recurrence. J Invest Surg. 2020;33(10):914–923. doi:https://doi.org/10.1080/08941939.2019.1586015.
- Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are MicroRNA targets. Cell. 2005;120(1):15–20. doi:https://doi.org/10.1016/j.cell.2004.12.035.
- Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868–874. doi:https://doi.org/10.1038/nature01323.
- Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145(3):341–355. doi:https://doi.org/10.1016/j.cell.2011.04.005.
- Brown BA, Connolly GM, Mill CEJ, et al. Aging differentially modulates the Wnt pro-survival signalling pathways in vascular smooth muscle cells. Aging Cell. 2019;18(1):e12844. doi:https://doi.org/10.1111/acel.12844.
- Malgor R, Bhatt PM, Connolly BA, et al. Wnt5a, TLR2 and TLR4 are elevated in advanced human atherosclerotic lesions. Inflamm Res. 2014;63(4):277–285. doi:https://doi.org/10.1007/s00011-013-0697-x.
- You LY, Chen H, Xu LX, Li X. Overexpression of miR-29a-3p suppresses proliferation, migration, and invasion of vascular smooth muscle cells in atherosclerosis via targeting TNFRSF1A. Biomed Res Int. 2020;2020:9627974. doi:https://doi.org/10.1155/2020/9627974.
- Sun DT, Xiang G, Wang J, et al. miRNA 146b-5p protects against atherosclerosis by inhibiting vascular smooth muscle cell proliferation and migration. Epigenomics. 2020;12(24):2189–2204. doi:https://doi.org/10.2217/epi-2020-0155.
- Yang F, Chen QS, He SP, et al. miR-22 is a novel mediator of vascular smooth muscle cell phenotypic modulation and neointima formation. Circulation. 2018;137(17):1824–1841. doi:https://doi.org/10.1161/CIRCULATIONAHA.117.027799.
- Feng SD, Gao L, Zhang DH, et al. MiR-93 regulates vascular smooth muscle cell proliferation, and neointimal formation through targeting Mfn2. Int J Biol Sci. 2019;15(12):2615–2626. doi:https://doi.org/10.7150/ijbs.36995.
- Zeng Z, Xia L, Fan X, et al. Platelet-derived miR-223 promotes a phenotypic switch in arterial injury repair. J Clin Invest. 2019;129(3):1372–1386. doi:https://doi.org/10.1172/JCI124508.
- Yuan L, Li Q, Zhang Z, et al. Tanshinone IIA inhibits the adipogenesis and inflammatory response in ox-LDL-challenged human monocyte-derived macrophages via regulating miR-130b/WNT5A. J Cell Biochem. 2020;121(2):1400–1408. doi:https://doi.org/10.1002/jcb.29375.
- Zhou B, Liu HY, Zhu BL, Yue AX. MicroRNA-141 protects PC12 cells against hypoxia/reoxygenation-induced injury via regulating Keap1-Nrf2 signaling pathway. J Bioenerg Biomembr. 2019;51(4):291–300. doi:https://doi.org/10.1007/s10863-019-09804-9.
- Zhou B, Yu JW . A novel identified circular RNA, circRNA_010567, promotes myocardial fibrosis via suppressing miR-141 by targeting TGF-β1. Biochem Biophys Res Commun. 2017;487(4):769–775. doi:https://doi.org/10.1016/j.bbrc.2017.04.044.
- Baseler WA, Thapa D, Jagannathan R, Dabkowski ER, Croston TL, Hollander JM. miR-141 as a regulator of the mitochondrial phosphate carrier (Slc25a3) in the type 1 diabetic heart. Am J Physiol Cell Physiol. 2012;303(12):C1244–C1251. doi:https://doi.org/10.1152/ajpcell.00137.2012.
- Yao B, Wan X, Zheng X, et al. Critical roles of microRNA-141-3p and CHD8 in hypoxia/reoxygenation-induced cardiomyocyte apoptosis. Cell Biosci. 2020;10:20. doi:https://doi.org/10.1186/s13578-020-00384-5.
- Zhang YD, Chen BN, Ming L, et al. MicroRNA-141 inhibits vascular smooth muscle cell proliferation through targeting PAPP-A. Int J Clin Exp Pathol. 2015;8(11):14401–14408.
- Gong D, Zhao ZW, Zhang Q, et al. The long noncoding RNA metastasis-associated lung adenocarcinoma transcript-1 regulates CCDC80 expression by targeting miR-141-3p/miR-200a-3p in vascular smooth muscle cells. J Cardiovasc Pharmacol. 2020;75(4):336–343.
- Zhang CC, Kong XH, Ma DL. miR-141-3p inhibits vascular smooth muscle cell proliferation and migration via regulating Keap1/Nrf2/HO-1 pathway. IUBMB Life. 2020;72(10):2167–2179. doi:https://doi.org/10.1002/iub.2374.